| 1 | Blocking MIF secretion enhances CAR T-cell efficacy against neuroblastoma | 4.9 | 19 | Citations (PDF) |
| 2 | A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence | 2.8 | 1 | Citations (PDF) |
| 3 | A technical review of multi-omics data integration methods: from classical statistical to deep generative approaches | 6.6 | 119 | Citations (PDF) |
| 4 | Proteomic-based stratification of intermediate-risk prostate cancer patients | 2.6 | 19 | Citations (PDF) |
| 5 | Heat ‘n Beat: A Universal High-Throughput End-to-End Proteomics Sample Processing Platform in under an Hour | 6.5 | 15 | Citations (PDF) |
| 6 | Retrospective analysis of clinical characteristics and outcomes of patients with carcinoma of unknown primary from three tertiary centers in Australia | 2.6 | 6 | Citations (PDF) |
| 7 | Proteomic insights into paediatric cancer: Unravelling molecular signatures and therapeutic opportunities | 1.3 | 6 | Citations (PDF) |
| 8 | DeePathNet: A Transformer-Based Deep Learning Model Integrating Multiomic Data with Cancer Pathways | 2.8 | 27 | Citations (PDF) |
| 9 | Clinical applications of mass spectrometry‐based proteomics in cancer: Where are we? | 3.1 | 62 | Citations (PDF) |
| 10 | Quantitative proteomic studies addressing unmet clinical needs in sarcoma | 2.6 | 12 | Citations (PDF) |
| 11 | qmotif: determination of telomere content from whole-genome sequence data | 2.4 | 15 | Citations (PDF) |
| 12 | Stanniocalcin2, but Not Stanniocalcin1, Responds to Hypoxia in a HIF1-Dependent Manner in the Retina | 2.7 | 8 | Citations (PDF) |
| 13 | Pan-cancer proteomic map of 949 human cell lines | 33.0 | 221 | Citations (PDF) |
| 14 | TOP3A
amplification and
ATRX
inactivation are mutually exclusive events in pediatric osteosarcomas using
ALT | 7.1 | 40 | Citations (PDF) |
| 15 | Targeted Therapy of
TERT
-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy | 6.8 | 33 | Citations (PDF) |
| 16 | Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX | 13.7 | 40 | Citations (PDF) |
| 17 | Functional characterization of miR-708 microRNA in telomerase positive and negative human cancer cells | 3.4 | 8 | Citations (PDF) |
| 18 | A novel cause of DKC1‐related bone marrow failure: Partial deletion of the 3′ untranslated region | 1.6 | 2 | Citations (PDF) |
| 19 | The C-Circle Biomarker Is Secreted by Alternative-Lengthening-of-Telomeres Positive Cancer Cells inside Exosomes and Provides a Blood-Based Diagnostic for ALT Activity | 3.8 | 26 | Citations (PDF) |
| 20 | Role of POT1 in Human Cancer | 3.8 | 64 | Citations (PDF) |
| 21 | Fibroblast-Derived STC-1 Modulates Tumor-Associated Macrophages and Lung Adenocarcinoma Development | 6.3 | 33 | Citations (PDF) |
| 22 | Strategies to enable large-scale proteomics for reproducible research | 13.7 | 135 | Citations (PDF) |
| 23 | Intronic TP53 Polymorphisms Are Associated with Increased Δ133TP53 Transcript, Immune Infiltration and Cancer Risk | 3.8 | 30 | Citations (PDF) |
| 24 | End Products of Telomere Research | 16.4 | 0 | Citations (PDF) |
| 25 | The FANCM-BLM-TOP3A-RMI complex suppresses alternative lengthening of telomeres (ALT) | 13.7 | 196 | Citations (PDF) |
| 26 | Synthetic lethality of cytolytic HSV-1 in cancer cells with ATRX and PML deficiency | 2.4 | 22 | Citations (PDF) |
| 27 | ∆133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signalling | 13.7 | 75 | Citations (PDF) |
| 28 | Telomere sequence content can be used to determine ALT activity in tumours | 15.5 | 49 | Citations (PDF) |
| 29 | Guidelines for whole genome bisulphite sequencing of intact and FFPET DNA on the Illumina HiSeq X Ten | 3.2 | 46 | Citations (PDF) |
| 30 | Limiting Thymic Precursor Supply Increases the Risk of Lymphoid Malignancy in Murine X-Linked Severe Combined Immunodeficiency | 5.5 | 24 | Citations (PDF) |
| 31 | Whole-genome landscape of pancreatic neuroendocrine tumours | 37.9 | 946 | Citations (PDF) |
| 32 | Withaferin-A kills cancer cells with and without telomerase: chemical, computational and experimental evidences | 8.5 | 58 | Citations (PDF) |
| 33 | BLM and SLX4 play opposing roles in recombination‐dependent replication at human telomeres | 7.3 | 174 | Citations (PDF) |
| 34 | MatCol: a tool to measure fluorescence signal colocalisation in biological systems | 3.4 | 22 | Citations (PDF) |
| 35 | Extensive Proliferation of Human Cancer Cells with Ever-Shorter Telomeres | 6.3 | 97 | Citations (PDF) |
| 36 | Comparative analysis of whole genome sequencing-based telomere length measurement techniques | 3.5 | 57 | Citations (PDF) |
| 37 | The C-Circle Assay for alternative-lengthening-of-telomeres activity | 3.5 | 133 | Citations (PDF) |
| 38 | Is cell culture a risky business? Risk analysis based on scientist survey data | 4.3 | 7 | Citations (PDF) |
| 39 | The wide‐ranging clinical implications of the short telomere syndromes | 0.8 | 38 | Citations (PDF) |
| 40 | A Study of
TP53
RNA Splicing Illustrates Pitfalls of RNA-seq Methodology | 3.8 | 33 | Citations (PDF) |
| 41 | DNA methylation mediated up-regulation ofTERRAnon-coding RNA is coincident with elongated telomeres in the human placenta | 2.9 | 33 | Citations (PDF) |
| 42 | A Common Cancer Risk-Associated Allele in the hTERT Locus Encodes a Dominant Negative Inhibitor of Telomerase | 3.2 | 42 | Citations (PDF) |
| 43 | Stanniocalcin-1 Inhibits Renal Ischemia/Reperfusion Injury via an AMP-Activated Protein Kinase-Dependent Pathway | 0.4 | 82 | Citations (PDF) |
| 44 | Coordinated epigenetic remodelling of transcriptional networks occurs during early breast carcinogenesis | 3.9 | 32 | Citations (PDF) |
| 45 | Molecular mechanisms of activity and derepression of alternative lengthening of telomeres | 8.8 | 205 | Citations (PDF) |
| 46 | Age-Adjusted Telomere Length May Predict Treatment-Related Mortality in Children Undergoing Hematopoietic Stem Cell TransplantationBlood, 2015, 126, 5445-5445 | 4.8 | 1 | Citations (PDF) |
| 47 | NuRD–ZNF827 recruitment to telomeres creates a molecular scaffold for homologous recombination | 8.8 | 121 | Citations (PDF) |
| 48 | Telomere extension by telomerase and ALT generates variant repeats by mechanistically distinct processes | 15.5 | 112 | Citations (PDF) |
| 49 | Molecular characterization of collaborator of ARF (CARF) as a DNA damage response and cell cycle checkpoint regulatory protein | 3.1 | 26 | Citations (PDF) |
| 50 | Synergistic tumor suppression by combined inhibition of telomerase and CDKN1A | 7.5 | 36 | Citations (PDF) |
| 51 | Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1Blood, 2014, 124, 2767-2774 | 4.8 | 116 | Citations (PDF) |
| 52 | STC1 expression is associated with tumor growth and metastasis in breast cancer | 2.6 | 111 | Citations (PDF) |
| 53 | Non‐telomerase telomere maintenance in human cells (97.2) | 0.6 | 0 | Citations (PDF) |
| 54 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer | 25.2 | 523 | Citations (PDF) |
| 55 | STC1 Expression By Cancer-Associated Fibroblasts Drives Metastasis of Colorectal Cancer | 3.8 | 166 | Citations (PDF) |
| 56 | Alternative lengthening of telomeres: remodeling the telomere architecture | 2.6 | 82 | Citations (PDF) |
| 57 | Stanniocalcin 1 is important for poststroke functionality, but dispensable for ischemic tolerance | 2.3 | 30 | Citations (PDF) |
| 58 | Alternative lengthening of telomeres in normal mammalian somatic cells | 4.6 | 130 | Citations (PDF) |
| 59 | Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway | 3.2 | 581 | Citations (PDF) |
| 60 | Variant repeats are interspersed throughout the telomeres and recruit nuclear receptors in ALT cells | 5.4 | 159 | Citations (PDF) |
| 61 | Five dysfunctional telomeres predict onset of senescence in human cells | 5.2 | 210 | Citations (PDF) |
| 62 | The role of telomere trimming in normal telomere length dynamics | 3.2 | 56 | Citations (PDF) |
| 63 | Detection of alternative lengthening of telomeres by telomere quantitative PCR | 15.5 | 82 | Citations (PDF) |
| 64 | Extreme Telomere Length Dimorphism in the Tasmanian Devil and Related Marsupials Suggests Parental Control of Telomere Length | 2.3 | 30 | Citations (PDF) |
| 65 | Loss of Wild-Type ATRX Expression in Somatic Cell Hybrids Segregates with Activation of Alternative Lengthening of Telomeres | 2.3 | 71 | Citations (PDF) |
| 66 | Telomerase activity in pleural malignant mesotheliomas | 2.6 | 22 | Citations (PDF) |
| 67 | Functional Polymorphisms in the TERT Promoter Are Associated with Risk of Serous Epithelial Ovarian and Breast Cancers | 2.3 | 54 | Citations (PDF) |
| 68 | Normal mammalian cells negatively regulate telomere length by telomere trimming | 2.9 | 99 | Citations (PDF) |
| 69 | MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3' untranslated region | 15.5 | 44 | Citations (PDF) |
| 70 | HP1-Mediated Formation of Alternative Lengthening of Telomeres-Associated PML Bodies Requires HIRA but Not ASF1a | 2.3 | 27 | Citations (PDF) |
| 71 | Presence of Alternative Lengthening of Telomeres Mechanism in Patients With Glioblastoma Identifies a Less Aggressive Tumor Type With Longer Survival | 1.8 | 83 | Citations (PDF) |
| 72 | Assaying and investigating Alternative Lengthening of Telomeres activity in human cells and cancers | 2.7 | 227 | Citations (PDF) |
| 73 | Check your cultures! A list of cross‐contaminated or misidentified cell lines | 4.3 | 477 | Citations (PDF) |
| 74 | Alternative lengthening of telomeres: models, mechanisms and implications | 46.9 | 936 | Citations (PDF) |
| 75 | Senescence: an antiviral defense that is tumor suppressive? | 2.8 | 54 | Citations (PDF) |
| 76 | Telomere elongation involves intra-molecular DNA replication in cells utilizing alternative lengthening of telomeres | 2.9 | 63 | Citations (PDF) |
| 77 | Induction of alternative lengthening of telomeres-associated PML bodies by p53/p21 requires HP1 proteins | 5.4 | 50 | Citations (PDF) |
| 78 | DNA Replication Licensing and Progenitor Numbers Are Increased by Progesterone in Normal Human Breast | 2.5 | 127 | Citations (PDF) |
| 79 | Telomerase activity is associated with an increase in DNA methylation at the proximal subtelomere and a reduction in telomeric transcription | 15.5 | 146 | Citations (PDF) |
| 80 | Normal human mammary epithelial cells proliferate rapidly in the presence of elevated levels of the tumor suppressors p53 and p21WAF1/CIP1 | 2.4 | 11 | Citations (PDF) |
| 81 | Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning | 2.9 | 67 | Citations (PDF) |
| 82 | Control of telomere length by a trimming mechanism that involves generation of t-circles | 7.3 | 194 | Citations (PDF) |
| 83 | DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity | 29.8 | 487 | Citations (PDF) |
| 84 | Spontaneous occurrence of telomeric DNA damage response in the absence of chromosome fusions | 8.8 | 255 | Citations (PDF) |
| 85 | Upregulation of survivin during immortalization of nontransformed human fibroblasts transduced with telomerase reverse transcriptase | 6.5 | 13 | Citations (PDF) |
| 86 | Stanniocalcin-1 acts in a negative feedback loop in the prosurvival ERK1/2 signaling pathway during oxidative stress | 6.5 | 55 | Citations (PDF) |
| 87 | Telomere uncapping and alternative lengthening of telomeres | 4.7 | 112 | Citations (PDF) |
| 88 | Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells | 3.9 | 162 | Citations (PDF) |
| 89 | The Murine Stanniocalcin 2 Gene Is a Negative Regulator of Postnatal Growth | 2.5 | 96 | Citations (PDF) |
| 90 | Disruption of Telomere Maintenance by Depletion of the MRE11/RAD50/NBS1 Complex in Cells That Use Alternative Lengthening of Telomeres | 2.2 | 138 | Citations (PDF) |
| 91 | Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference | 6.5 | 107 | Citations (PDF) |
| 92 | Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesis | 4.3 | 219 | Citations (PDF) |
| 93 | The Murine Stanniocalcin 1 Gene Is Not Essential for Growth and Development | 2.5 | 62 | Citations (PDF) |
| 94 | Suppression of Alternative Lengthening of Telomeres by Sp100-Mediated Sequestration of the MRE11/RAD50/NBS1 Complex | 2.5 | 146 | Citations (PDF) |
| 95 | Activation of the ALT pathway for telomere maintenance can affect other sequences in the human genome | 2.9 | 26 | Citations (PDF) |
| 96 | hnRNP A2, a potential ssDNA/RNA molecular adapter at the telomere | 15.5 | 79 | Citations (PDF) |
| 97 | The first molecular details of ALT in human tumor cells | 2.9 | 191 | Citations (PDF) |
| 98 | Telomere Biology: A New Player in the End Zone | 3.6 | 28 | Citations (PDF) |
| 99 | Molecular Markers and Long-term Survivors of Glioblastoma Multiforme | 1.8 | 1 | Citations (PDF) |
| 100 | Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme | 62.1 | 258 | Citations (PDF) |
| 101 | Overexpressed mortalin (mot-2)/mthsp70/GRP75 and hTERT cooperate to extend the in vitro lifespan of human fibroblasts | 3.1 | 96 | Citations (PDF) |
| 102 | Alternative lengthening of telomeres, telomerase, and cancer | 8.6 | 181 | Citations (PDF) |
| 103 | A Major Functional Difference between the Mouse and Human ARF Tumor Suppressor Proteins | 2.2 | 29 | Citations (PDF) |
| 104 | CARF Is a Novel Protein That Cooperates with Mouse p19 (Human p14 ) in Activating p53 | 2.2 | 62 | Citations (PDF) |
| 105 | Hsp70 Family Member, mot-2/mthsp70/GRP75, Binds to the Cytoplasmic Sequestration Domain of the p53 Protein | 3.1 | 168 | Citations (PDF) |
| 106 | Comparison of human mammary epithelial cells immortalized by simian virus 40 T-Antigen or by the telomerase catalytic subunit | 6.5 | 134 | Citations (PDF) |
| 107 | Alternative lengthening of telomeres in mammalian cells | 6.5 | 603 | Citations (PDF) |
| 108 | Molecular characterization of inter-telomere and intra-telomere mutations in human ALT cells | 25.2 | 121 | Citations (PDF) |
| 109 | Telomere maintenance and cancer ? look, no telomerase | 60.7 | 142 | Citations (PDF) |
| 110 | Title is missing! 2002 | | 5 | Citations (PDF) |
| 111 | Effects of Simian Virus 40 T-Antigens on Normal Human Mammary Epithelial Cells Reveal Evidence for Spontaneous Alterations in Addition to Loss of p16INK4a Expression | 3.1 | 12 | Citations (PDF) |
| 112 | An N-terminal Region of Mot-2 Binds to p53 In Vitro | 7.0 | 63 | Citations (PDF) |
| 113 | Alternative Lengthening of Telomeres in Human Cells | 2.1 | 104 | Citations (PDF) |
| 114 | Pex19p Dampens the p19ARF-p53-p21WAF1 Tumor Suppressor Pathway* | 2.2 | 41 | Citations (PDF) |
| 115 | Coexistence of Alternative Lengthening of Telomeres and Telomerase in hTERT-Transfected GM847 Cells | 2.5 | 236 | Citations (PDF) |
| 116 | Stanniocalcin 1 and 2 are secreted as phosphoproteins from human fibrosarcoma cells | 3.8 | 78 | Citations (PDF) |
| 117 | Telomere maintenance by recombination in human cells | 25.2 | 832 | Citations (PDF) |
| 118 | The role of senescence and immortalization in carcinogenesis | 2.8 | 211 | Citations (PDF) |
| 119 | Structurally and Functionally Distinct Mouse Hsp70 Family Members Mot-1 and Mot-2 Proteins are Encoded by Two Alleles | 2.8 | 25 | Citations (PDF) |
| 120 | Identification of a Novel Human Mitochondrial D-Loop RNA Species Which Exhibits Upregulated Expression Following Cellular Immortalization | 2.1 | 9 | Citations (PDF) |
| 121 | Transcriptional Inactivation of p53 by Deletions and Single Amino Acid Changes in Mouse mot-1 Protein | 2.1 | 16 | Citations (PDF) |
| 122 | p53 Localizes to the Centrosomes and Spindles of Mitotic Cells in the Embryonic Chick Epiblast, Human Cell Lines, and a Human Primary Culture: An Immunofluorescence Study | 3.1 | 79 | Citations (PDF) |
| 123 | Inactivation of p53 and life span extension of human diploid fibroblasts by mot-2 | 2.7 | 73 | Citations (PDF) |
| 124 | The hTERTα Splice Variant is a Dominant Negative Inhibitor of Telomerase Activity | 7.0 | 200 | Citations (PDF) |
| 125 | p16INK4a and the control of cellular proliferative life span | 2.8 | 102 | Citations (PDF) |
| 126 | Cloning and Characterization of a Novel Gene,striamin, That Interacts with the Tumor Suppressor Protein p53 | 2.2 | 5 | Citations (PDF) |
| 127 | Constructing immortalized human cell lines | 6.8 | 44 | Citations (PDF) |
| 128 | Downregulation of metallothionein-IIA expression occurs at immortalization | 6.5 | 23 | Citations (PDF) |
| 129 | Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids | 6.5 | 103 | Citations (PDF) |
| 130 | Expression and localisation of stanniocalcin 1 in rat bladder, kidney and ovary | 2.6 | 19 | Citations (PDF) |
| 131 | A reassessment of the telomere hypothesis of senescence | 2.1 | 57 | Citations (PDF) |
| 132 | Telomere maintenance mechanisms and cellular immortalization | 3.2 | 173 | Citations (PDF) |
| 133 | Telomere maintenance mechanisms and cellular immortalization | 3.2 | 0 | Citations (PDF) |
| 134 | Identification of a 55-kDa Ezrin-Related Protein That Induces Cytoskeletal Changes and Localizes to the Nucleolus | 3.1 | 27 | Citations (PDF) |
| 135 | Genes Involved in the Control of Cellular Proliferative Potentiala | 4.0 | 44 | Citations (PDF) |
| 136 | Differential display of mRNA | 2.0 | 49 | Citations (PDF) |
| 137 | Identification of a second stanniocalcin cDNA in mouse and human: Stanniocalcin 2 | 3.4 | 110 | Citations (PDF) |
| 138 | Telomere Length Dynamics in Telomerase-Positive Immortal Human Cell Populations | 3.1 | 109 | Citations (PDF) |
| 139 | Human Stanniocalcin (STC): Genomic Structure, Chromosomal Localization, and the Presence of CAG Trinucleotide Repeats | 2.8 | 32 | Citations (PDF) |
| 140 | Correction of the Copper Transport Defect of Menkes Patient Fibroblasts by Expression of the Menkes and Wilson ATPases | 2.2 | 100 | Citations (PDF) |
| 141 | Inactivation of Tumor Suppressor p53 by Mot-2, a hsp70 Family Member | 2.2 | 214 | Citations (PDF) |
| 142 | Isolation of a Candidate Human Telomerase Catalytic Subunit Gene, Which Reveals Complex Splicing Patterns in Different Cell Types | 2.9 | 539 | Citations (PDF) |
| 143 | The Telomere Lengthening Mechanism in Telomerase-Negative Immortal Human Cells Does Not Involve the Telomerase RNA Subunit | 2.9 | 184 | Citations (PDF) |
| 144 | Telomere dynamics and telomerase activity in in vitro immortalised human cells | 4.9 | 210 | Citations (PDF) |
| 145 | Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines | 33.0 | 1,245 | Citations (PDF) |
| 146 | Reassessment of immortalization complementation group D | 3.7 | 5 | Citations (PDF) |
| 147 | Normal telomere maintenance in immortal ataxia telangiectasia cell lines | 1.8 | 29 | Citations (PDF) |
| 148 | Genetic Differences between the Pancytosolic and Perinuclear Forms of Murine Mortalin | 3.1 | 26 | Citations (PDF) |
| 149 | Characteristics of tumor cell bioactivity in oncogenic osteomalacia | 3.4 | 60 | Citations (PDF) |
| 150 | Molecular cloning and characterization of mouse stanniocalcin cDNA | 3.4 | 83 | Citations (PDF) |
| 151 | Chromosomal changes and progressive tumorigenesis of human bronchial epithelial cell lines | 1.2 | 15 | Citations (PDF) |
| 152 | Alterations in p53 and p16
INK4
Expression and Telomere Length during Spontaneous Immortalization of Li-Fraumeni Syndrome Fibroblasts | 2.5 | 256 | Citations (PDF) |
| 153 | Sv40-induced immortalization andras-transformation of human bronchial epithelial cells | 4.3 | 45 | Citations (PDF) |
| 154 | Immortalization of human fibroblasts by liposome-mediated transfer of SV40 early region genes | 0.6 | 8 | Citations (PDF) |
| 155 | Telomere elongation in immortal human cells without detectable telomerase activity. | 7.3 | 1,123 | Citations (PDF) |
| 156 | A novel human cDNA highly homologous to the fish hormone stanniocalcin | 3.4 | 211 | Citations (PDF) |
| 157 | Correlation between Complementation Group for Immortality and the Cellular Distribution of Mortalin | 3.1 | 82 | Citations (PDF) |
| 158 | HPV-16 E6 and E7 Genes, like SV40 Early Region Genes, Are Insufficient for Immortalization of Human Mesothelial and Bronchial Epithelial Cells | 3.1 | 29 | Citations (PDF) |
| 159 | SV40-lnduced Immortalization of Human Cells | 0.9 | 196 | Citations (PDF) |
| 160 | Assignment of SV40-Immortalized Cells to More Than One Complementation Group for Immortalization | 3.1 | 57 | Citations (PDF) |
| 161 | Immortalization and characterization of human cell lines with mast cell and monocytic properties | 2.7 | 6 | Citations (PDF) |
| 162 | Human mesothelioma cells and asbestos-exposed mesothelial cells are selectively resistant to amosite toxicity: a possible mechanism for tumor promotion by asbestos | 2.8 | 8 | Citations (PDF) |
| 163 | Effects of exogenous wild-type p53 on a human lung carcinoma cell line with endogenous wild-type p53 | 3.1 | 30 | Citations (PDF) |
| 164 | Finite life span of hybrids formed by fusion of different simian virus 40-immortalized human cell lines | 3.6 | 22 | Citations (PDF) |
| 165 | Oncogenes and tumor-suppressor genes. | 8.3 | 18 | Citations (PDF) |
| 166 | A human bronchial epithelial cell strain with unusualin vitro growth potential which undergoes neoplastic transformation after SV40 T antigen gene transfection | 4.3 | 11 | Citations (PDF) |
| 167 | Oncogenes and Tumor-Suppressor Genes | 8.3 | 2 | Citations (PDF) |
| 168 | Control of growth and squamous differentiation in normal human bronchial epithelial cells by chemical and biological modifiers and transferred genes. | 8.3 | 45 | Citations (PDF) |
| 169 | Enhancement of the invasive ability of a transformed human bronchial epithelial cell line by 12-O-tetra-decanoyl-phorbol-13-acetate and diacylglycerol | 2.8 | 19 | Citations (PDF) |
| 170 | Tumorigenicity of Human Mesothelial Cell Line Transfected With EJ-ras Oncogene | 4.6 | 27 | Citations (PDF) |
| 171 | Invasive and Metastatic Potential of a v-Ha-ras-Transformed Human Bronchial Epithelial Cell Line | 4.6 | 95 | Citations (PDF) |
| 172 | Control of Growth and Squamous Differentiation in Normal Human Bronchial Epithelial Cells by Chemical and Biological Modifiers and Transferred Genes | 8.3 | 3 | Citations (PDF) |
| 173 | Human bronchial epithelial cells with integrated SV40 virus T antigen genes retain the ability to undergo squamous differentiation | 2.4 | 172 | Citations (PDF) |
| 174 | Neoplastic transformation of a human bronchial epithelial cell line by a recombinant retrovirus encoding viral harvey ras | 3.1 | 68 | Citations (PDF) |
| 175 | Strontium Phosphate Transfection of Human Cells in Primary Culture: Stable Expression of the Simian Virus 40 Large-T-Antigen Gene in Primary Human Bronchial Epithelial Cells | 2.5 | 35 | Citations (PDF) |
| 176 | Cell cycle effects of iron depletion on T-47D human breast cancer cells | 3.1 | 30 | Citations (PDF) |
| 177 | Tamoxifen stimulation of human breast cancer cell proliferation in vitro: a possible model for tamoxifen tumour flare | 0.7 | 104 | Citations (PDF) |
| 178 | N-Desmethyltamoxifen inhibits growth of MCF 7 human mammary carcinoma cells in Vitro | 0.7 | 8 | Citations (PDF) |
| 179 | Effects of oestrogens on cell proliferation and cell cycle kinetics. A hypothesis on the cell cycle effects of antioestrogens | 0.7 | 91 | Citations (PDF) |
| 180 | Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle | 0.7 | 187 | Citations (PDF) |
| 181 | Title is missing! 0 | | 2 | Citations (PDF) |
| 182 | Federated Deep Learning Enables Cancer Subtyping by Proteomics | 25.1 | 10 | Citations (PDF) |
| 183 | Mapping the Proteomic Landscape of Pancreatic Cancer: Prognostic Insights and Subtype Stratification | 2.8 | 2 | Citations (PDF) |
| 184 | Predictive Biomarkers of Antibody–Drug Conjugate Efficacy for Solid Tumors: Current Challenges and the Potential Role of Quantitative Proteomics | 6.8 | 2 | Citations (PDF) |
| 185 | OnCorr: A pan-cancer mRNA-protein correlation tool for precision oncology | 6.5 | 1 | Citations (PDF) |
